Q2
CDNA — Q2 2026 Financial Report Analysis
CareDx revenue rose 52% to $131.9M on 17% test-volume growth plus about $16M of catch-up collections; GAAP EPS of $2.07 is almost entirely a $113M gain on selling its lab products unit, while 2026 revenue guidance was raised to $490–500M.